SCHEMBL30201133

SCHEMBL30201133

CCOc1cccc(OCCNC(=N)CNc2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
KDM4E B2RXH2 5/20 0.46
ALDH1A1 P00352 3/20 0.46
TDP1 Q9NUW8 1/20 0.46
LMNA P02545 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
F10 P00742 1/20 0.44
MTNR1A P48039 2/20 0.44
MTNR1B P49286 2/20 0.44
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
RECQL P46063 2/20 0.41
F2 P00734 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NSD2 O96028 1/20 0.41
MAPT P10636 1/20 0.40
ALOX12 P18054 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30201037 0.85 DRD2 (0.54) MAPK1KDM4ELMNAF10NPC1
Hydrochloric Acid SCHEMBL8054960 0.70 MAPK1 (0.75) MAPK1CYP1A2CYP2D6CYP2C19LMNA
SCHEMBL5290036 0.70 HTT (0.55) MAPK1KDM4EALDH1A1LMNANPC1
SCHEMBL16673625 0.68 F2 (0.76) MAPK1CYP1A2CYP2D6CYP2C19KDM4E
1,3-Diethoxybenzene SCHEMBL1100167 0.67 TP53 (0.71) MAPK1CYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL7986906 0.67 MAPT (0.54) MAPK1KDM4EALDH1A1LMNAL3MBTL1
SCHEMBL30201042 0.67 MTNR1A (0.56) ALDH1A1LMNAMTNR1AMTNR1BNPC1
SCHEMBL25182698 0.66 ALDH1A1 (0.57) MAPK1CYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL9145377 0.66 POLB (0.51) MAPK1CYP1A2CYP2D6CYP2C19MTNR1A
SCHEMBL8725186 0.66 DRD4 (0.61) ALDH1A1L3MBTL1MTNR1AMTNR1BNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023028086-A1 COMBINATIONS OF PERIPHERAL 5-HT2A RECEPTOR ANTAGONISTS AND CENTRAL 5-HT2A RECEPTOR AGONISTS GILGAMESH PHARMACEUTICALS, INC. (US) 2023-03-02 WO disclosed